Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified sodium hyaluronate is a derivative of hyaluronic acid, a naturally occurring glycosaminoglycan found in the extracellular matrix of various tissues. Chemical modifications, often involving cross-linking, enhance its stability, cohesiveness, and resistance to enzymatic degradation, thereby prolonging its persistence in tissues. This makes it suitable for use as a dermal filler, where it physically occupies space, restores volume, and attracts water to hydrate tissues, effectively correcting wrinkles and folds. It is utilized in cosmetic procedures for facial rejuvenation, such as the correction of moderate to severe nasolabial fold wrinkles. Lanzhou Biotechnique Development Co., Ltd. is involved in its development and distribution.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified sodium hyaluronate.